CytoDyn Inc. (CYDY)
OTCMKTS
· Delayed Price · Currency is USD
0.2510
-0.0086 (-3.29%)
Aug 14, 2025, 10:08 AM EDT
CytoDyn Employees
CytoDyn had 13 employees as of May 31, 2025. The number of employees increased by 4 or 44.44% compared to the previous year.
Employees
13
Change (1Y)
4
Growth (1Y)
44.44%
Revenue / Employee
n/a
Profits / Employee
$174,000
Market Cap
325.38M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
American Oncology Network | 1,914 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 116 |
CytoDyn News
- 19 days ago - CytoDyn files $100M mixed securities shelf - Seeking Alpha
- 6 weeks ago - CytoDyn Announces Encouraging Survival Data in Patients with Metastatic Colorectal Cancer Previously Treated with Leronlimab - GlobeNewsWire
- 7 weeks ago - CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer - GlobeNewsWire
- 2 months ago - A Penny Stock To Watch In Challenging Cancer Space - Benzinga
- 3 months ago - CytoDyn Releases ESMO Breast Cancer Meeting Poster - GlobeNewsWire
- 3 months ago - CytoDyn highlights potential of lead drug against solid tumors with new data - Seeking Alpha
- 3 months ago - CytoDyn Announces Data Suggesting Novel Mechanism of Action of Leronlimab for the Treatment of Solid Tumors - GlobeNewsWire
- 3 months ago - CytoDyn appoints Robert Hoffman as CFO - Seeking Alpha